SpaceRx is a small-molecule therapeutics company focused on addiction and respiratory rescue. We are developing next-generation treatments for nicotine addiction, tailored to individual needs, with the goal of helping more people quit and stay quit.
CDC reports that 11.6% of U.S. adults smoked cigarettes in 2022. Despite major progress in reducing smoking rates, smoking remains the leading preventable cause of disease and death in the United States, and smoking and secondhand smoke exposure together cause more than 480,000 deaths annually, underscoring the urgent need for more effective cessation therapies.
Building on our expertise in CNS pharmacology, SpaceRx is also developing a first-in-class, non-opioid approach to restore respiratory function in opioid- and polysubstance-induced overdoses.

SpaceRx

Org chart

Teams

Offices

SpaceRx

Org chart

Teams

Offices

Related companies